Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yung-Chih Kuo & Rajendiran Rajesh. (2019) Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors. Expert Review of Neurotherapeutics 19:7, pages 623-652.
Read now
Read now
Callum Ross, Mark Taylor, Nigel Fullwood & David Allsop. (2018) Liposome delivery systems for the treatment of Alzheimer’s disease. International Journal of Nanomedicine 13, pages 8507-8522.
Read now
Read now
Govindarajan Karthivashan, Palanivel Ganesan, Shin-Young Park, Joon-Soo Kim & Dong-Kug Choi. (2018) Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease. Drug Delivery 25:1, pages 307-320.
Read now
Read now
Yung-Chih Kuo & Chien-Wei Tsao. (2017) Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin. International Journal of Nanomedicine 12, pages 2857-2869.
Read now
Read now
Articles from other publishers (35)
Farhan Mazahir & Awesh K. Yadav. (2023) Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment
of Alzheimer’s Disease. CNS & Neurological Disorders - Drug Targets 22:4, pages 477-499.
Crossref
Crossref
Ramkumar Subramaniyan, Rajalakshmi Ramarajan, Arulraj Ramalingam, Sivakumar Sambandam, Amalraj Petersamy, Ahlam Roufieda Guerroudj, Nourdine Boukabcha & Abdelkader Chouaih. (2023) Microwave assisted synthesis, vibrational spectra, Hirshfeld surface and interaction energy, DFT, topology, in silico ADMET and molecular docking studies of 1,2-bis(4-methoxybenzylidene)hydrazine. Journal of Molecular Structure 1278, pages 134946.
Crossref
Crossref
Carrie D. Johnston, Erika G. Marques de Menezes, Scott Bowler, Eugenia L. Siegler, Courtney Friday, Philip J. Norris, Michelle C. Rice, Mary E. Choi, Marshall J. Glesby & Lishomwa C. Ndhlovu. (2023) Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV. Journal of NeuroVirology.
Crossref
Crossref
Raghuram Kandimalla, Mohd Saeed, Neetu Tyagi, Ramesh C. Gupta & Farrukh Aqil. (2023) Exosome-based approaches in the management of Alzheimer’s disease. Neuroscience & Biobehavioral Reviews 144, pages 104974.
Crossref
Crossref
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral & Paulo C. Costa. (2023) Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases. Colloids and Surfaces B: Biointerfaces 221, pages 112999.
Crossref
Crossref
Mukta Agrawal, Upal Roy & Amit Alexander. 2023. Nanomedicine-Based Approaches for the Treatment of Dementia. Nanomedicine-Based Approaches for the Treatment of Dementia
149
168
.
Yasamin Davatgaran Taghipour, Amir Zarebkohan, Roya Salehi, Fariborz Rahimi, Vladimir P. Torchilin, Michael R. Hamblin & Alexander Seifalian. (2022) An update on dual targeting strategy for cancer treatment. Journal of Controlled Release 349, pages 67-96.
Crossref
Crossref
William M. Pardridge. (2022) A Historical Review of Brain Drug Delivery. Pharmaceutics 14:6, pages 1283.
Crossref
Crossref
Carely Hernandez & Surabhi Shukla. (2022) Liposome based drug delivery as a potential treatment option for Alzheimer’s disease. Neural Regeneration Research 17:6, pages 1190.
Crossref
Crossref
Davood Gheidari & Mohammad Bayat. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
17
39
.
Xiaoyu Yuan, Zhi Jia, Jin Li, Yanan Liu, Yuqin Huang, Youcong Gong, Xian Guo, Xu Chen, Jieqiong Cen & Jie Liu. (2021) A diselenide bond-containing ROS-responsive ruthenium nanoplatform delivers nerve growth factor for Alzheimer's disease management by repairing and promoting neuron regeneration. Journal of Materials Chemistry B 9:37, pages 7835-7847.
Crossref
Crossref
Cristina Quispe, Natália Cruz-Martins, Maria Letizia Manca, Maria Manconi, Oksana Sytar, Nataliia Hudz, Mariia Shanaida, Manoj Kumar, Yasaman Taheri, Miquel Martorell, Javad Sharifi-Rad, Gianfranco Pintus & William C. Cho. (2021) Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases. Oxidative Medicine and Cellular Longevity 2021, pages 1-15.
Crossref
Crossref
Irina Kurokin, Anna Andrea Lauer, Daniel Janitschke, Jakob Winkler, Elena Leoni Theiss, Lea Victoria Griebsch, Sabrina Melanie Pilz, Veronika Matschke, Martin van der Laan, Heike Sabine Grimm, Tobias Hartmann & Marcus Otto Walter Grimm. (2021) Targeted Lipidomics of Mitochondria in a Cellular Alzheimer’s Disease Model. Biomedicines 9:8, pages 1062.
Crossref
Crossref
Yamir Islam, Andrew G. Leach, Jayden Smith, Stefano Pluchino, Christopher R. Coxon, Muttuswamy Sivakumaran, James Downing, Amos A. Fatokun, Meritxell Teixidò & Touraj Ehtezazi. (2021) Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles. Advanced Science 8:11.
Crossref
Crossref
Hoda E. Mohamed, Mervat E. Asker, Mohamed A. Shaheen, Rana G. Eissa & Nahla N. Younis. (2021) Alleviation of fructose‐induced Alzheimer’s disease in rats by pioglitazone and decaffeinated green coffee bean extract. Journal of Food Biochemistry 45:5.
Crossref
Crossref
Sukriti Srivastava, Razi Ahmad & Sunil Kumar Khare. (2021) Alzheimer’s disease and its treatment by different approaches: A review. European Journal of Medicinal Chemistry 216, pages 113320.
Crossref
Crossref
Annu, Ali Sartaj, Nidhi Aggarwal, Zufika Qamar, Heena Tabassum, Jasjeet K. Narang, Sanjula Baboota & Javed Ali. 2021. Nanocarriers for the Delivery of Combination Drugs. Nanocarriers for the Delivery of Combination Drugs
47
83
.
Yana Zorkina, Olga Abramova, Valeriya Ushakova, Anna Morozova, Eugene Zubkov, Marat Valikhov, Pavel Melnikov, Alexander Majouga & Vladimir Chekhonin. (2020) Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 25:22, pages 5294.
Crossref
Crossref
Mariafrancesca Cascione, Valeria De Matteis, Stefano Leporatti & Rosaria Rinaldi. (2020) The New Frontiers in Neurodegenerative Diseases Treatment: Liposomal-Based Strategies. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2020) Particulate systems for improving therapeutic efficacy of pharmaceuticals against central nervous system-related diseases. Journal of the Taiwan Institute of Chemical Engineers 114, pages 12-23.
Crossref
Crossref
Fereshteh Bayat, Reza Hosseinpour-Moghadam, Fatemeh Mehryab, Yousef Fatahi, Niayesh Shakeri, Rassoul Dinarvand, Timo L.M. Ten Hagen & Azadeh Haeri. (2020) Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation. Advances in Colloid and Interface Science 277, pages 102121.
Crossref
Crossref
Hossein Derakhshankhah, Soraya Sajadimajd, Samira Jafari, Zhila Izadi, Sajad Sarvari, Majid Sharifi, Mojtaba Falahati, Faezeh Moakedi, Willis Collins Akeyo Muganda, Mareike Müller, Mohammad Raoufi & John F. Presley. (2020) Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 24, pages 102149.
Crossref
Crossref
Jihong Huang, Xing Lyu, Aimei Liao, Yi Zhao, Yinchen Hou, Wenjing Chen & Canrui Yang. (2019) Proteomics-based analysis of functional proteins after fermentation of compound wheat embryo Chinese medicine. Grain & Oil Science and Technology 2:3, pages 57-61.
Crossref
Crossref
Kevin Liaw, Zhi Zhang & Sujatha Kannan. (2019) Neuronanotechnology for brain regeneration. Advanced Drug Delivery Reviews 148, pages 3-18.
Crossref
Crossref
Juhi Samal, Ana Lucia Rebelo & Abhay Pandit. (2019) A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders. Advanced Drug Delivery Reviews 148, pages 68-145.
Crossref
Crossref
Xiangru Feng, Jiannan Li, Xi Zhang, Tongjun Liu, Jianxun Ding & Xuesi Chen. (2019) Electrospun polymer micro/nanofibers as pharmaceutical repositories for healthcare. Journal of Controlled Release 302, pages 19-41.
Crossref
Crossref
Zi-Ying Wang, Sravan Gopalkrishnashetty Sreenivasmurthy, Ju-Xian Song, Jing-Yi Liu & Min Li. (2019) Strategies for brain-targeting liposomal delivery of small hydrophobic molecules in the treatment of neurodegenerative diseases. Drug Discovery Today 24:2, pages 595-605.
Crossref
Crossref
Alexander V. Zholos, Olesia F. Moroz & Maksim V. Storozhuk. (2019) Curcuminoids and Novel Opportunities for the Treatment of Alzheimer's Disease: Which Molecules are Actually Effective?. Current Molecular Pharmacology 12:1, pages 12-26.
Crossref
Crossref
Josef Jampílek, Katarína Kráľová, Petr Novák & Michal Novák. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
65
138
.
Miora Rakotoarisoa & Angelina Angelova. (2018) Amphiphilic Nanocarrier Systems for Curcumin Delivery in Neurodegenerative Disorders. Medicines 5:4, pages 126.
Crossref
Crossref
Yung-Chih Kuo & He-Cheng Tsai. (2018) Rosmarinic acid- and curcumin-loaded polyacrylamide-cardiolipin-poly(lactide-co-glycolide) nanoparticles with conjugated 83-14 monoclonal antibody to protect β-amyloid-insulted neurons. Materials Science and Engineering: C 91, pages 445-457.
Crossref
Crossref
Gang Xu, Xiao Liu, Yachun Shu, Jagan A. Pillai & Yan Xu. (2018) A rapid and sensitive LC–MS/MS method for quantitative analysis of cardiolipin (18:2)4 in human leukocytes and mouse skeletal muscles. Journal of Pharmaceutical and Biomedical Analysis 158, pages 386-394.
Crossref
Crossref
Bushra Nabi, Saleha Rehman, Saba Khan, Sanjula Baboota & Javed Ali. (2018) Ligand conjugation: An emerging platform for enhanced brain drug delivery. Brain Research Bulletin 142, pages 384-393.
Crossref
Crossref
Yung-Chih Kuo & I-Hsin Wang. (2017) Using catanionic solid lipid nanoparticles with wheat germ agglutinin and lactoferrin for targeted delivery of etoposide to glioblastoma multiforme. Journal of the Taiwan Institute of Chemical Engineers 77, pages 73-82.
Crossref
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2017) Targeted delivery of rosmarinic acid across the blood–brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide- co -glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E. International Journal of Pharmaceutics 528:1-2, pages 228-241.
Crossref
Crossref